Filana Therapeutics (FLNA) traded down -1.54 % during a 24 hours period ending at 10:14 PM Central Europe on Monday 26th. One Filana Therapeutics stock can currently be bought for about USD 0.61 on popular exchanges. Current supply of Filana Therapeutics stocks is 48 mn. Filana Therapeutics has a current market capitalization of USD 30.7 mn and approximately USD 199.1 k worth of Filana Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Filana Therapeutics has traded -16.88 % down. Simple moving average of last 200 days is at USD 1.39. The highest price of past 52 weeks was recorded at USD 3.81 on 10/28/2025. 52 weeks low was at USD 0.62 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Gaia (GAIA) traded up 0.7 % and now trades at USD 1.28. Gaia has a market capitalisation of USD 36.4 mn.
Mount Logan Capital (MLCI) traded down -0.93 % and now trades at USD 3.17. Current market capitalisation for Mount Logan Capital is USD 35.9 mn.
Cryo-cell (CCEL) traded down -0.67 % and now trades at USD 5.01. Cryo-cell has a market capitalisation of USD 35.9 mn.
Cineverse (CNVS) traded down -1.95 % and now trades at USD 1.48. Cineverse has a market capitalisation of USD 35.9 mn.
Biote (BTMD) traded down -1.83 % and now trades at USD 1.15. Biote has a market capitalisation of USD 36.3 mn.
About Filana Therapeutics
Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas, United States. The company specializes in detecting and treating neurodegenerative diseases such as Alzheimer’s. Cassava Sciences serves clients in the United States and can be accessed through their website at www.cassavasciences.com . The company went public on the Nasdaq stock exchange on July 14, 2000.
